Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
1-((3-((1-Piperazinyl)carbonyl)phenyl)methyl)-2,4(1H,3H)-quinazolinedione derivatives as PARP inhibitors for treating cancer
No-Receipt date
2019-02850 - 26/07/2019
No-Filing date
20190402290 - 26/07/2019
No-Granting date
3100713 - 02/10/2019
No-EPO application date
12765230.3 - 31/03/2012
No-EPO granting date
2709990 - 12/06/2019
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
10/2019 - 28/11/2019
Expiration date
01/04/2032
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
CN20111008247501/04/2011/CN
WOPCT/CN2011/07703411/07/2011/WO
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/517
A61P 35/00
A61P 9/00
C07D 239/96
C07D 401/06
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1055822
IMPACT THERAPEUTICS, INC.
FLOOR 9 10 XINGHUO ROAD NANJING
JIANGSU 210061
CHINA (PEOPLE'S REPUBLIC OF)
Inventors
Code
Firstname
Surname
2660344
CAI, SUI XIONG
2660345
TIAN, YE EDWARD
2660346
DONG, HAIJUN
2660347
XU, QINGBING
2660348
WU, LIZHEN
2660349
LIU, LIJUN
2660350
JIANG, YANGZHEN
2660351
BAO, QINGLI
2660352
WANG, GUOXIANG
2660353
YIN, FENG
2660354
GU, CHENGYUN
2660355
HU, XIUHUA
2660356
WANG, XIAOZHU
2660357
KANG, SISHUN
2660358
CHEN, SHENGZHI
Representatives
Code
Firstname
Surname
Address
Town
Zip
3098
ANNA
GIAKOUMI
ALKAMENOUS 12-14
ATHINA (ATTIKIS)
10439
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8397
ANDRONIKI
MISIOU
ANALIPSEOS 23 KAI MARATHONOS 27
VRILISSIA (ATTIKIS)
15235
GREECE
Owners History
Title Instruments
Payments history
14 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).